SCUEL — Japan healthcare data

HomeTherapeutic areas › Agents for parasitic skin diseases

Japan market screening · Therapeutic class

Agents for parasitic skin diseases in Japan

寄生性皮ふ疾患用剤 · Japan Standard Commodity Classification

14 molecules in this class are marketed in Japan across 78 products. 47 of those products are not shipping normally today — 60.3% of the class. Supply status is reported to the Ministry of Health, Labour and Welfare and updated daily.

14Molecules
78Marketed products
47Products constrained

Molecules in this class

Ordered by how many products compete. Constrained means limited supply or supply suspended; supply suspended does not mean discontinued.

MoleculeProducts CompaniesConstrained Supply mix
Terbinafine Hydrochlorideテルビナフィン塩酸塩231410
Ketoconazoleケトコナゾール1059
Butenafine Hydrochlorideブテナフィン塩酸塩635
Lanoconazoleラノコナゾール625
Luliconazoleルリコナゾール634
Oxiconazole Nitrateオキシコナゾール硝酸塩62
Bifonazoleビホナゾール544
Clotrimazoleクロトリマゾール331
Neticonazole Hydrochlorideネチコナゾール塩酸塩313
Salicylic Acidサリチル酸322
Liranaftateリラナフタート212
Miconazole Nitrateミコナゾール硝酸塩211
Sulconazole Nitrateスルコナゾール硝酸塩21
Amorolfine Hydrochlorideアモロルフィン塩酸塩111
Normal supply Limited supply Supply suspended

How to read this

Products counts every marketed product across all strengths and forms, not companies. Companies is the number of companies marketing that molecule; the same company may appear under several molecules, so the column does not add up to a class total. Market size sits on each molecule's own page, valued at national price rather than transaction price. Figures are as at 2026-08-28.

Screening this area in Japan?

Tell us which molecules matter to you. We will tell you what the public data can and cannot answer before you commission anything.

Send an enquiry

Our Database Division replies in English within three business days (Japan time).